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ABSTRACT

THE EFFECTS OF PERCEIVED RISK AND RESPONSIBILITY ON THE
ACCEPTANCE OF A HUMAN PAPILLOMAVIRUS VACCINE BY COLLEGE MEN
by
Angela Marie Mitiguy
University of New Hampshire, September, 2009

In the summer of 2006 the Food and Drug Administration approved a new
vaccine to prevent four types of the Human Papillomavirus believed to cause the majority
of genital warts and cervical cancer in women. Since that time the vaccine has
experienced considerable uptake among women while it has also been met by some
criticism. Current medical research aims to understand if the vaccine, which has been
approved only for women, could be used to prevent HPV in men.
Little empirical research has been conducted to understand whether or not men
would be willing to receive a vaccine for a sexually transmitted infection that poses few
serious health risks for them. This research investigates the level of acceptance among a
sample of males at a large public university in New Hampshire as well as some of the
possible predictors of men's acceptance of a Human Papillomavirus vaccine.
Specifically, men's perceived risk for contracting the virus and its possible health
consequences and their perceived sense of responsibility for sexual behavior will be
examined as predictors of vaccine acceptance.

INTRODUCTION

In the summer of 2006 a new vaccine was approved by the Food and Drug
Administration to prevent the spread of certain strands of the Human Papillomavirus
(HPV)

in

women

(http://www.cdc.gov/vaccines/vpd-vac/hpv/hpv-vacsafe-effic.htm,

2007). HPV is the most commonly spread sexually transmitted infection in the United
States

and

the

cause

of

several

types

of

cervical

cancer

(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008, Goldstein, 2008). Just over two
years after its initial introduction medical research is now examining the possibility of a
vaccine

aimed

at preventing

vac/hpv/hpv-vacsafe-effic.htm,

HPV

in men

(http://www.cdc.gov/vaccines/vpd-

2007). While the female vaccine has experienced

considerable uptake, it is important to understand whether or not men would be willing to
accept and receive this vaccine after nearly two years of the vaccine being marketed
mainly as a cervical cancer prevention vaccine. How will men's perception of their own
risk for contracting HPV and their views on sexual behavior responsibility impact their
decision to receive the vaccine if one ever becomes available for them?
This study aims to investigate the effect of men's perceptions surrounding risk
and responsibility on the acceptance of a male HPV vaccine. While previous research has
examined the factors surroundings parents' decision making in regards to vaccinating
their children (e.g. Brabin et al., 2006, Marlow et al., 2007) and men and women's
willingness to vaccinate (Jones and Cook, 2008), no known prior research has looked
specifically at the effects of perceived risk and responsibility on men's acceptance of a

1

male HPV vaccine. This study also aims to understand the effects, if any, of men's
exposure to the current Gardasil1 marketing campaign on their understanding of HPV and
their willingness to receive a vaccine.
This report will begin with a review of the literature surrounding sexual behavior
responsibility regarding contraceptive use and unwanted pregnancy as a theoretical
structure to frame the current HPV vaccine situation. I will then review the current
research that is available on the Human Papillomavirus vaccine in regards to attitudes
about the vaccine and willingness to vaccinate either one's self or one's child. This will
include literature regarding the effects of level of knowledge about the virus and vaccine,
demographic factors, and gender.

Overall Contribution
There are gender differences when it comes to expectations in sexual
responsibility. Previous research has looked at the social processes that have created an
environment in which women are primarily responsible for contraceptive use and are
expected to be the responsible partner in a sexual relationship (e.g. Oudshoorn, 2003).
With new advancements in medical technologies to combat one of the most common
sexually transmitted infections it is important to understand how these social
constructions might affect the uptake of HPV vaccines by both sexes. The medical field
and vaccine technologies in particular are continually growing and changing and it is
important for Medical Sociology to continue to grow with and understand the social

1

Gardasil is the leading Human Papillomavirus vaccine currently available for women. It is manufactured
and marketed by Merck & Co. More information about the Gardasil vaccine and the marketing campaign
around it will be presented in chapter II.
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implications of these technologies on men and women and the social factors that
influence how they are accepted and used by society.

Practical Implications
The Human Papillomavirus is one of the most prevalent sexually transmitted
infections and has become the center of a great deal of medical research. Companies have
already begun marketing and producing a vaccine to prevent HPV in women but women
are not the only people to contract HPV. The Human Papillomavirus is not purely a
women's health issue. Men do contract the virus and there are medical consequences
associated with HPV for them as well. Currently, medical research is investigating the
possibility of a vaccine that would prevent HPV in men. This study could help inform
researchers as to whether or not men would be willing to receive an HPV vaccine or
whether they should solely continue to promote and market the female vaccine.

3

CHAPTER I

LITERATURE REVIEW

The Human Papillomavirus
The Human Papillomavirus (HPV) is a common infection that is passed on
through genital contact, usually through vaginal or anal sex. Most individuals are not
aware they have HPV because many times it does not carry any symptoms. There are an
estimated 40 different strands of HPV, with some types causing genital warts in both
males and females and other types causing up to 95% of cervical cancer cases. HPV is
the most common sexually transmitted infection in the United States, with approximately
20 million Americans currently infected and an additional 6.2 million people contracting
the infection annually. Approximately 50% of sexually active men and women will
acquire an HPV infection at some point in their lifetime. HPV is most common among
people in their late teens and twenties. High-risk HPV has the ability to transform normal
cells into abnormal cells, which can result in more serious medical complications. Most
of the time the body will fight off the infection on its own and the virus will clear within
two years (http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). HPV does have
specific health consequences for men and women although women are at a greater risk
for both contracting the virus and developing more serious health issues.
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The Human Papillomavirus and Women. Certain strands of HPV and persistent
cases of the virus have the ability to cause cervical cancer in women. In high-risk cases a
woman can have HPV for many years during which time those abnormal virus cells may
become cancerous. Approximately 10% of women who have high-risk HPV on their
cervix will develop persistent HPV infections which could put them at risk for cervical
cancer. Researchers suggest that up to 95% of all cervical cancer cases in the United
States are caused by these strands of HPV. The American Cancer Society estimated that
11,070 women would be diagnosed with cervical cancer in 2008. Unfortunately, cervical
cancer does not usually present any symptoms until it is has reached an advanced stage so
it is extremely important for women to undergo regular cervical cancer screenings
(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). Clearly, HPV poses a serious
health risk to women.

The Human Papillomavirus and Men. While men contract the Human
Papillomavirus, they are less likely to get the virus than women are. Few men will know
that they actually have the infection as it usually does not present any symptoms. There
are some complications that result from certain strands of HPV in men, including genital
warts, and penile and anal cancers. The rates of these cancers are significantly lower than
the rates of cancer in women; therefore, HPV does not pose as much of a risk to men as it
does to women. Penile cancer only affects 1 in every 100,000 men in the United States.
The American Cancer Society estimates that 1,250 men will be diagnosed with penile and
other male genital cancers in 2008. Only about 1% of sexually active men in the United
States will have genital warts at any one time. Currently there is no way to test for the
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virus in men nor is there a vaccine like there is for women. Research is investigating the
possibility of using the current vaccine for men or of developing a vaccine specifically
for male use (http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008).

The Human Papillomavirus Vaccine
Presently, there is a vaccine available for women which prevents four types of
HPV, types 6, 11, 16, and 18, that cause most cervical cancer and genital warts
(http://www.gardasil.eom/what-is-gardasil/information-on-gardasil/index.html#nine,
2008). The vaccine is recommended for girls who are between 11 and 12 years old and is
available for women through 26 years of age who have not yet had the vaccine or
completed the three shot series. It is recommended that girls receive the vaccine before
becoming sexually active because the vaccine works best for women who have not yet
encountered any of the strands of HPV and does not work as well for women who have
been

exposed

to

the

infection

before

getting

the

vaccine

(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008). Currently, there is no approved
vaccine for men, although research is examining the possibility of a vaccine to prevent
HPV in men or if the female vaccine will be effective in men.

Breakdown by Demographic Characteristics
Research has looked at the acceptance of the HPV vaccine among different sociodemographic groups. Brabin et al. (2006) found that socio-demographic characteristics
made no difference between those parents who approved of the vaccine for their children
and those who did not. Ethnicity and age of respondent were not statistically associated
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with vaccine acceptance (Brabin et al., 2006). Lenselink et al. (2008) found that gender
and age were statistically related to vaccine acceptance among young adults, with women
and younger participants being more willing to vaccinate themselves against HPV. In a
study of mothers in England, Marlow et al. (2007) found that demographic characteristics
such as mother's level of education, ethnic background, employment and marital status
did not affect their acceptance of the vaccine. Age of respondent and relationship status
will be used in the current study as demographic variables.

Knowledge about the HPV Vaccine
Previous research on the HPV vaccine has aimed to investigate whether or not the
amount of knowledge a person has about the vaccine will affect their decision to have
their child receive it. Dempsey et al. (2006) found that when participants were provided
with a fact sheet containing information about HPV and its vaccine they scored higher on
a HPV assessment. The increased knowledge provided by the HPV information sheet did
not increase the likelihood that participants would accept the vaccine (Dempsey et al,
2006). Lenselink et al. (2007) also found that increased knowledge about HPV and
cervical cancer would not mean increased acceptance of the vaccine and that overall
about 88% of their sample would accept the vaccine regardless of differences in several
independent variables, including level of education and marital status. This raises the
question of whether or not the 88% acceptance is the result of all of the effort to publicize
the vaccine. In a more recent study Lenselink et al. (2008) found that knowledge of HPV,
and knowledge of cervical cancer were not statistically associated with young Dutch
adults' acceptance of a Human Papillomavirus vaccine.
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Perception of Sexual Behavior Responsibility
Previous research has examined the relationship between gender and sexual
behavior responsibility. Grady et al. (1996) found that men were more than twice as
likely to say that they believed men held the majority of responsibility in contraceptive
decision making as they were to say that women did. If men believe that they are to be
the partner responsible for contraceptive decision making then perhaps this will extend to
their decision making for vaccine prevention. Therefore, men who believe that men hold
the majority of sexual behavior responsibility will be more willing to vaccinate compared
to those who believe that sexual responsibility should be a woman's concern.
Other research has examined a similar development in the medical field in which
medical technology investigated the development of male hormonal contraceptive pill
and while this pill was easily developed in the lab there were several social hurdles that
made it unsuccessful in practice (Oudshoorn, 2003). Oudshoorn (2003) suggests that one
of these hurdles was including men as responsible partners in family planning practices.
Previously men had not been included in the discourse on family planning and
contraceptive use was seen primarily as a woman's responsibility (Oudshoorn, 2003).
While it seems that medical research may be able to develop the male HPV vaccine fairly
quickly this does not assure that society will be ready and will to accept it and that men
will be willing to vaccinate.
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Perception of Risk
Jones and Cook (2008) conducted a study that addressed university men and
women's intentions to receive an HPV vaccine. This study found that among college age
men and women both groups reported a high intent to receive the vaccine. Men were
more likely to report an intention to receive the vaccine if the vaccine would prevent
genital warts and cervical cancer then they would be if the vaccine only prevented
cervical cancer (Jones and Cook, 2008). Boehner et al. (2003) also found that one of the
predictors of college students' acceptance of a Human Papillomavirus vaccine was
whether or not students had numerous sexual partners, suggesting that the higher
students' perception of risk for contracting the disease, the more likely they would be
willing to accept a vaccine to prevent infections. Like Jones and Cook (2008), this study
also found an overall high vaccinate acceptance (approximately 74%) for a Human
Papillomavirus vaccine and a genital herpes vaccine (Boehner et al., 2003).
These studies were conducted before the vaccine to prevent HPV in women
became available in the summer of 2006. In November of 2006 Merck & Co., the
creators of Gardasil, launched a comprehensive print, television and online campaign to
market the vaccine to girls and women, age 9 to 26. The campaign's slogan, "One Less,"
is aimed at encouraging women to be "one less" woman who will have to battle cervical
cancer. Since then there have been two years of marketing the vaccine as a cervical
cancer prevention, with less attention being paid to genital warts or other complications.
Would men be less likely to intend to receive the vaccine now that they have been
exposed to these commercials which describe HPV as a primarily female health problem?
This study aimed to explore the effects of this campaign on vaccine decision making.
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Gaps in the Literature
While the previous research on the Human Papillomavirus and the vaccine has
targeted parental intention to vaccinate children and looked at basic socio-demographic
differences in regards to decision making, very little has investigated the response men
might have to the vaccine and the factors that may affect their decision making. This
study aims to fill this gap in the literature and hopefully inform researchers of the
possible uptake of a male vaccine if one becomes available. This study works as an
acceptability study aimed at understanding whether or not a new population will welcome
a new technology and hopefully informing the direction this line of medical research
should take in the future. Acceptability was defined by Marshall in 1977 as "a quality
which makes an object, person, event, or idea pleasing or welcome" (Marshall, 1977: 65).
The overall goal of this project is to fill a gap in the current HPV vaccine literature by
adding men's acceptance of an HPV vaccine to the information that is presently
available.
While previous research has focused on knowledge of the virus and vaccine as
predictors of acceptance, this study will focus on the effects of perceived risk and
responsibility, largely socially constructed, that may affect uptake. It is hypothesized that
men's beliefs surrounding their level of risk for contracting the Human Papillomavirus
and the medical consequences associated with it will be the result of how society has
presented information on this relatively new health topic instead of being based on actual
medical facts. This could be the result of current marketing campaigns for the women's
vaccine as well as the present discussion that surrounds HPV.
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In a similar manner the level of responsibility that men feel they should take in
protecting themselves against the Human Papillomavirus may not be an accurate
reflection of this level of risk. For example, because HPV is prevalent among men and
has serious medical complications they should be interested in protecting themselves
against the virus, but perhaps their level of responsibility instead reflects whether or not
society has encouraged them to take responsibility for their sexual behavior and the
consequences associated with it. As a basis for this idea, a book by Nelly Oudshoorn
(2003) will be used. This work, in part, looks at the effect that male responsibility had on
the development of a male contraceptive pill. These two medical technologies, a male
contraceptive pill and a male HPV vaccine, raise parallel issues because of the effects
which both topics, unwanted pregnancy and HPV, have on women compared to men.
This study can be seen as an extension of Oudshoorn's work as it addresses one of the
current advancements in biomedical research which differentiates men and women.
In response to the gaps in the current literature that have been outlined above, I
have investigated the following hypotheses:

Hypotheses
Hypothesis I. Men who report a greater perceived risk for contracting HPV and
the medical complications associated with it will be more likely to accept and receive a
future vaccine.
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X= perceived
risk for HPV
Controls= age,
major,
relationship
status

Y= decision to
receive the
HPV vaccine

Hypothesis II. Men who believe that women are primarily responsible for the use of
contraceptives will be less likely to accept and receive the HPV vaccine.

X= perceived
responsibility
for sexual
behavior

Y= decision to
receive the
HPV vaccine

Controls= age,
major,
relationship
status

Hypothesis III. Men who report having been exposed to the current Gardasil commercials
for HPV will be more likely to reject getting the vaccine. This could be a result of the fact
that men who have been exposed to Merck's marketing campaign will view HPV as more
of a women's health issue and the vaccine as more of a cervical cancer prevention
vaccine instead of a sexually transmitted infection prevention. This relationship will be
mediated by participants' perceived risk of contracting the infection.

12

X= reported
exposure to
HPV vaccine
commercials
Controls= age,
race, major,
relationship
status

Z= perceived
risk for HPV
Y= decision to
receive the
HPV vaccine
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CHAPTER II

THEORETICAL FRAMEWORK

This research will draw on the area of sexual responsibility research to create a
framework in which one can understand men's relationship to the Human Papillomavirus
and the vaccine. Primarily, research looking at men's views of contraception
responsibility will be used to establish how men view contraceptive use and who they
feel should take control of preventing unwanted pregnancy as well as contracting other
sexually transmitted infections. Specifically, research on preventing and contracting HIV
will be used as an example of this.
Some similarities can be established between gendered experiences of HPV and
unwanted pregnancy that rationalize the use of this research for the current study.
Because men are not directly affected by unwanted pregnancy, compared to women, they
may feel that women should take more responsibility for preventing pregnancy. The same
similarities can be seen with the Human Papillomavirus, because women experience
more negative consequences from the virus, men may feel that HPV is more of a
women's sexual health issue and therefore it is more their responsibility to protect against
contracting the virus. Similarities can also be seen between HPV and HIV because
women can contract both infections easier than men can. A woman is much more likely
to contract HIV during vaginal intercourse than a man is (Padian, Shiboski, and Jewell,
1991). The Human Papillomavirus is also more easily transmitted from a man to a
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woman

than

from

a

woman

to

a

man

during

sexual

intercourse

(http://www.cdc.gov/std/HPV/STDFact-HPV.htm, 2008).
This study will explore the effect of gender socialization on vaccine acceptance
among college age men, specifically looking at their perception of risk and sexual
behavior responsibility. These perceptions may be the result of larger socialization
patterns that have tended to place a heavier burden of responsibility for sexual behavior
on women then on men and the result of a marketing campaign that promotes HPV
primarily as a woman's sexual health issue. If men see their risk for infection and sense
of responsibility as being low then they will be less accepting of an HPV vaccine to
prevent the infection in men. Lower levels of perceived risk may be associated with
exposure to current HPV vaccine commercials that present it as a cervical cancer
prevention tool.
Nelly Oudshoorn's book, The Male Pill (2003), examines the challenges
surrounding the attempt to introduce a hormonal contraceptive pill for male use, even
though one had easily been developed scientifically. Oudshoorn (2003) suggests that the
acceptance of a contraceptive pill for men relies heavily on a shift in attitudes
surrounding reproductive responsibility. The obstacles do not lie in the scientific field but
rather in the cultural (Oudshoorn, 2003).
An important strategy in the advocacy of male involvement in family
planning has thus consisted of counteracting the dominant cultural
narratives on men and family planning. This was only a first step in
changing family planning discourse toward the inclusion of men. Another
equally, or maybe even more, important part of the cultural work of men
and family planning advocates consisted of changing the objectives and
vocabulary of family planning (Oudshoorn, 2003: 123).
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Oudshoorn's work is an important resource for this study because it relates very
closely to this paper's topic. She suggests that the development of the family planning
industry focused mainly on women and the use of female contraceptive pills because the
medical field had a long history of viewing sex and reproduction as closer to the nature of
women than to the nature of men and this "natural" connection made women an obvious
subject of special research in the medical field (Oudshoorn, 2003). Because female
bodies were seen as being naturally closer to reproduction, the medical community
suggested that it was "more natural" and easier to interrupt the process of ovulation than
to disrupt the production of sperm cell (Oudshoorn, 2003). With a strong focus on women
and a belief that women are somehow more closely connected to reproduction, men have
largely been left out of the discourse on family planning and sexual behavior
responsibility that has emerged out of the medical community. It seems logical that this
disregard for male participation in family planning may extend to their involvement in
sexually transmitted infection prevention.
Oudshoorn (2003) suggests that we can use contraceptive technologies for
understanding how certain forms of gender gain cultural dominance in society while
other forms remain largely marginalized. The view that women's bodies are at the center
of sex makes them the focus of discussion and research and leaves men detached and
unaccounted for. Oudshoorn (2003) writes that "the predominance of contraceptives for
women contributed to a stabilization of performances of gender, which constituted a
strong alignment between femininity and contraceptive use" (Oudshoorn, 2003:16). This
view has dominated for several decades and has shaped how we view gender differences
in sexual behavior responsibility.
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The results of this research could have possible theoretical and practical
implications for the field of sociology and the understanding of the uptake of new
medical technologies. In regards to sociology this study would contribute largely to the
area of a medical sociology as well as to the area of gender. This research also has
practical implications for the introduction and acceptance of new medical information
and may inform medical researchers about the direction they should be taking in
furthering the prevention of HPV. Male acceptance of this vaccine could also provide
important insight into their acceptance of possible future vaccines for other diseases, such
as HIV, because both are sexually transmitted diseases and may carry a certain level of
stigma.
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CHAPTER III

METHODS

The goal of this research is to understand college men's acceptance of a Human
Papillomavirus vaccine and factors that may predict variation in acceptance. The research
design for this study is a cross-sectional survey design. A questionnaire was administered
aimed at addressing the three main hypothesis discussed earlier, mainly participants'
perceived risk of getting HPV and the complications associated with the infection, their
sense of responsibility for sexual health and sexual responsibility and their exposure to
current HPV vaccine advertisements. This last set of questions addressed whether or not
participants have seen any of the HPV vaccine advertisements currently running in order
to assess their effect on acceptance of a male vaccine. All statistical analyses were
conducted using the computer program, Stata.

Sample
The sample for this study is college age men. Participants were recruited from a
large state university in a northeastern state. These participants were enrolled in general
education classes at the time of this study in an attempt to gain a representative sample of
the college population. Classes were randomly sampled from each of the nine sections of
general education courses at the university by assigning each course a number and then
randomly drawing classes from each section. The professor for each course was
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contacted via an e-mail which explained the nature of the study and asked for their
assistance in recruiting male participants from their course. A copy of the recruitment
letter that was sent to professors can be found in Appendix A at the end of this report. If
professors declined to participate then additional courses within the same section were
sampled so that there was representation from all nine of the types of general education
classes. The goal sample size was approximately 200.
Unfortunately, there was difficultly establishing the size of the sample that was
originally desired. While the sampling technique was sound, there was an overall
unwillingness of college professors to extend the survey to their male students. After
several rounds of sampling and contacting professors the study yielded approximately 80
male participants. There is an overall difficulty in getting this particular demographic
group to respond to survey questionnaires. It could be that individuals in this
demographic are unwilling to participant in social science research in general or that the
use of the internet survey was not successful with this particular group because it required
participants to go to the survey on their own. The response rate may have been higher if
surveys were administered in class but it seems like it may have been difficult to collect
data this way because of the difficulty in gaining assistance from some professors. Future
attempts to gain access to this population may be more successful if there were more
resources available and more desirable incentives for participants.

Measures
The measures for this study were included in the questionnaire which was sent to
the participants using the online survey provider Survey Monkey. The survey began with
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several questions aimed at addressing certain demographic characteristics of the sample.
Other parts of the survey included scales with items aimed at creating measures of
perceived risk, perceived sexual behavior responsibility, and the effects of HPV vaccine
advertising. Each of the measurements will be described in detail below. All measures
can be found in Appendix B at the end of this report.

Independent Variables
Perception of Risk The first independent variable was participants' perceptions of
their risk of contracting the Human Papillomavirus and the risk of developing possible
complications associated with the infection. This variable was measured by asking
participants to express how real they feel the possibility is for them to contract HPV, how
important of an issue they feel HPV is, and whether or not they feel they feel at risk for
the infection. Responses were provided by giving level of agreement on a Likert scale
with low responses corresponding to low levels of perceived risk and high response
corresponding to higher perceived risk.

Perception of Responsibility. The second independent variable was participants'
perceptions of sexual responsibility. Items aimed to address who participants feel is most
responsible for contraception, themselves or a possible sexual partner, and who should be
responsible for dealing with unplanned pregnancies, men or women. This section of items
aimed to understand whether or not beliefs about sexual behavior responsibility and
contraception use can extend to a willingness to protect against sexually transmitted
infections by receiving a vaccine. The items used to address participants' sexual behavior
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responsibility come from The Gender-Equitable Men Scale (GEM Scale) created by
Pulerwitz and Barker (2007).

Exposure to HPV Vaccine Advertisements. In the summer of 2006 a vaccine was
introduced to prevent HPV in women, specifically two types most commonly associated
with causing cervical cancer and two other types thought to cause genital warts. In order
to promote the vaccine several advertisements have been created aimed at encouraging
young women and mothers to get the vaccine for themselves or their daughters. These
commercials largely describe the vaccine as a prevention for cervical cancer. The
question becomes, will men be less inclined to think that HPV is a sexually transmitted
infection that affects men if they have been exposed to commercials that promotes it
primarily as a women's health issue? The final section of this survey asked participants to
provide information regarding their exposure to the current HPV vaccine campaign as
well as a few open-ended questions which aimed to understand what effects, if any, these
advertisements have on their understanding of HPV and current prevention strategies.

Control Variables
The following variables were used as control variables during the analysis of this
data: age, residency, and relationship status. Age was categorized as 18 years old, 19
years old, 20 years old, 21 years old, 22 years old, and 23 and older. Residency asked
students whether they are in-state students or out-of-state students. Finally, relationship
status asked respondents to categorize their current status as either single, casually dating,
in a serious relationship, cohabitating with a partner, or married.
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Dependent Variable
Decision to Receive the Vaccine. In order to assess whether or not respondents
would accept a possible male HPV vaccine, they were asked whether or not they would
personally receive the vaccine if one ever became available. The respondents were asked
to disregard the cost of the vaccine or whether or not their insurance would cover the cost
when making a decision about their willingness to vaccinate. This was because I wanted
to understand how participants felt about the importance of vaccinating themselves
regardless of the effects of financial constraints.

Mediating Variable
Perception of Risk. The level of risk participants perceive they are at for
contracting HPV can also be a mediating variable between their exposure to HPV vaccine
advertisements and their decision to receive the vaccine. It is possible that viewing these
advertisements may reduce participants' perceived risk because they portray HPV as a
predominately female health issue, resulting in men thinking that it is purely a women's
health issue and not something that they are at risk for and should be concerned with.

Procedure
After a list of nine general education courses were sampled and participation was
approved by the instructors of the courses, the survey link was e-mailed to professors so
that it could be offered to their male students either through e-mail or through their
course website. Participants could then access the survey when and wherever they wanted
and complete the five minute questionnaire. Participants were also given the opportunity
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to enter their names in a raffle for a chance to win a gift certificate to a local electronics
store.

Limitations of the Methodology
The largest limitation to the current study is the ability to generalize the findings
to a larger population of men. This is because the sample is from a large university in a
predominately white northeastern state and is not representative of the national
population. Another

limitation surrounds the effects

of exposure to Human

Papillomavirus advertisements on acceptance of male vaccine. It is impossible to fully
understand the extent of this effect without conducting an experiment in a laboratory
setting with a control group. The best that can be done is to rely on participants' reports
of their experiences with these advertisements.
Another possible limitation to this study which relates to the sample is the issue of
response bias. It could be, and quite possibly is, that those male college students who
chose to participate in a study regarding a sexually transmitted infection are different
from those male college students who chose not to participate. This possible difference
could be a major limitation to this study and to understanding what the male college
population really believes about protecting about the Human Papillomavirus and what
their future behavior would be regarding their decision to vaccinate if a vaccine does
become available for them. Instead of understanding the male college population as a
whole, this study may only address the beliefs of a specific type of male college student.
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Human Subjects Research
This research used human subjects for data collection so it was imperative that all
steps were taken to ensure that no harm would come to participants. This study was
approved by the Institutional Review Board at the University of New Hampshire. A copy
of the letter of approval from the Institutional Review Board can be found in Appendix E.

Protection of Human Subjects. In order to fully protect all study participants there
were certain procedures taken to ensure participants' consent, safety and privacy.
Appendix B provides an example of the consent form that participants had to read and
agree to before they completed the survey. The consent form explained that all the
information provided would remain confidential and that the participants would remain
anonymous in any work that resulted from this research. Respondents' names were in no
way associated with the information they provided in the survey.
Although there were no immediate risk to participants the questions that were
asked may have raised some levels of anxiety as some deal with sexual promiscuity and
sexually transmitted infections. A list of resources, including those that can provide more
information about sexually transmitted infections and those that provide further
information about the Human Papillomavirus and the current vaccine, were be provided
to participants at the end of the survey. The list of resources provided to participants can
be found in Appendix D at the end of this report. Respondents were informed that the
greatest benefit of participating in this study was the contribution that they were able to
make to a larger body of knowledge. Another possible benefit to participating in this
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study was the opportunity to participate in a raffle drawing and the possibility of winning
a gift certificate to a local computer store.
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CHAPTER IV

RESULTS

The data collected for this study was analyzed using the statistical computer
program, Stata. This chapter will begin with a section of descriptive statistics, which will
aim to illustrate the group of college men which constitute this particular sample. Tables
will then be presented that examine the relationship between the items addressing sexual
behavior responsibility and perceived risk for the Human Papillomavirus and
respondents' age and relationship status. This will be done to examine if there is a
relationship between the age or current relationship status of participants and their
agreement with each of the statements found under these two categories of sexual
behavior responsibility and perceived risk.
I will then examine the effects of perceived sexual behavior responsibility on
vaccine acceptance by looking at the items aimed at addressing their beliefs surrounding
contraceptive use and handling unwanted pregnancy. The next section will evaluate the
relationship between vaccine acceptance and perceived risk for the virus. The purpose of
these two analyses is to determine if one's views on sexual behavior responsibility and
their perception of risk for HPV will influence their willingness to vaccinate against the
infection. Basic cross-tabulations and chi-square tests were conducted to examine the
significance between the items for sexual behavior responsibility and perceived risk for
HPV and the population as well as the population's willingness to vaccinate. Finally, I
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will address the effects of exposure to the current Gardasil campaign on vaccine
acceptance, including participants' open-ended responses, which have been categorized
and presented in a table.

Descriptive Statistics
Table 1. Summary statistics
Variable

n

%

Mean age of all respondents (19.5)
18-19
20+

42
37

53.2
46.8

In-state Status
In-state student
Out-of-state student

47
26

64.4
35.6

Relationship Status
Single
Casually dating
In a serious relationship
Cohabitating
Married

42
11
18
1
1

57.5
15.1
24.7
1.4
1.4

Willingness to vaccinate
Very willing
Somewhat willing
Neither willing nor unwilling
Somewhat unwilling
Very unwilling

17
25
21
3
2

25.0
36.8
30.9
4.4
2.9

A summary of the descriptive statistics for this population can be found in Table
1. Seventy-nine undergraduate male students from a large state university in a North
Eastern state responded to the internet survey that was available on Survey Monkey. Of
these 79 respondents only 68 actually completed the entire survey. Participants' ages
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ranged from 18 to 23 years old with the average age being 19.5 years. Age was collapsed
and categorized as those who reported being 18 or 19 and those who were 20 or older.
Approximately 52% of the respondents were 18 or 19 years old and 48% were 20 years
old or older. These two categories of age will be used when the variable age is used in
any further statistical analyses.
One of the first questions on the survey addressed whether respondents are instate students or out-of-state students. In this sample, approximately 64% of respondents
reported being in-state students and 36% reported being out-of-state students. This
question was asked in order to establish what percentage of the sample was from the
small northeastern state where the university was located. If a large percentage of the
population reported being from this state then it may affect the results as the sample may
not be as representative of this demographic.
The beginning of the survey also asked participants to express what their current
relationship status would be. Seventy-three percent of respondents claimed to currently
be either single or casually dating, while 25% claimed to be in a serious relationship. The
other 2% of respondents were either married or cohabitating with a partner. This two
percent was dropped from consideration during analysis because it represented such a
small percentage of the sample and was only a few participants. The other categories
were also collapsed so that those respondents who were currently single could be
compared to those who were in exclusive relationships. In order to do this, those who
reported either being single or casually dating were collapsed into one category which
from now one will be considered single. This category was compared to those who
reported being in a serious relationship.
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Vaccine Acceptance
The central item from this survey was whether or not individuals would be willing
to receive an HPV vaccine if one ever became available. Participants were asked to
disregard cost or insurance coverage when responding to this item. Sixty-two percent of
the participants reported being willing to receive a vaccine, only 7% reported being
completely unwilling to vaccinate, and the remaining 31% of participants reported being
neither willing nor unwilling to receive a vaccine. For statistical purposes this 31% was
collapsed with those who reported being unwilling. The goal of this analysis is to
examine what is different between those individuals who would be willing to vaccinate
from everyone else. Those respondents who reported feeling neutral about their decision
to vaccinate and those who would choose not to vaccinate were collapsed together
because of the small sample size. It was also important to this study to be able to establish
characteristics and attitudes of those who would definitely be willing to vaccinate against
the HPV vaccine from those who are not. The responses for this question can also be
found in Table 1.

Sexual Behavior Responsibility
Each of the seven items in the section of the survey dealing with sexual behavior
responsibility were compared to respondents' age and relationship status and chi-square
tests were conducted to determine if there was a relationship between any of these items
with the age or relationship status of a respondents.
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Table 2. Chi-square of Sexual Behavior Responsibility by Age and Relationship Status
Age
18-19
%

Relationship
20+
%

X?

Exclusive
%

Single
%

Z2

Sexual Behavior Responsibility
It is the man who decides what type
of sex to have.
Agree
Disagree
It is a woman's responsibility to
avoid getting pregnant.
Agree
Disagree
I would be outraged if my sexual
partner asked me to use a condom.
Agree
Disagree
A couple should decide together if
they want to have children.
Agree
Disagree
In my opinion, a woman can
suggest using a condom just like a
man can.
Agree
Disagree
If a guy gets a woman pregnant, the
child is the responsibility of both.
Agree
Disagree

2.02
61.9
38.1

45.9
54.1

0.00
61.1
38.9

60.4
39.6

2.84
59.0
41.0

38.7
61.3

0.96
41.2
58.8

54.9
45.1
2.83

0.23
4.8
95.2

2.7
97.3

11.1
89.9

1.9
98.1

1.45
90.5
9.5

0.61
88.9
11.1

81.1
18.9

94.3
5.7
0.12

0.15

94.9
5.1

96.8
3.2

94.1
5.9

96.1
3.9

0.80
90.5
9.5

83.8
16.2

0.00
94.4
5.6

94.3
5.7

A man and a woman should decide
together what type of contraceptive
to use.
Agree
Disagree

94.9
5.1

96.7
3.3

100.0
0.0

94.0
6.0

Total (n)

42

37

18

53

0.13

1.07

*p<.05 **p<.01
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In Table 2, I present the results of the cross-tabulations and chi-square tests for
sexual responsibility against age and relationship status. The table presents the
percentages of those respondents who agreed and disagreed with the provided statements
based on their age and their relationship status. In order to compare these variables the
original categories for agreement were collapsed. The original categories "agree" and
"somewhat agree" were combined together and were compared to those individuals who
responded that they disagreed with the statement. None of these seven items under sexual
behavior responsibility were statistically related to either the respondents' age or their
reported relationship status. The first item on this list asked for respondents' agreement
with the following statement: "It is the man who decides what type of sex to have."
Almost 62% of 18 or 19 years old agreed with this statement, compared to approximately
38% who disagreed. When comparing this group with the other age group, approximately
46% of those 20 years and older agreed with this statement, while 54% of those 20 and
older disagreed with it.
Another item from the sexual behavior responsibility section that was compared
with age and relationship status was the relationship between with the third statement in
this section, "I would be outraged if my sexual partner asked me to use a condom," and
relationship status. Of those who reported being in an exclusive relationship,
approximately 89% disagreed with this statement compared with about 11% who agreed
with this statement. For those respondents who reported currently being single only 2%
agreed with this statement and approximately 98% disagreed.
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Perceptions of Risk
Table 3. Chi-square of Perceived Risk for Contracting HPV with Age and Relationship
Status
Relationship

Age
18-19
%

20+
%

X2

Exclusive
%

Single
%

X2

Perceived HPV Risk
Men are just as likely to contract
the Human Papillomavirus as
women.
Agree
Disagree
The medical complications of
HPV are just as severe for men
as they are for women.
Agree
Disagree
HPV is the leading cause of
penile and anal cancers in men.
Agree
Disagree
It is just as important for men to
protect themselves against HPV
as it is for women.
Agree
Disagree
Total (n)

0.77

52.4
47.6

62.2
37.8

0.01

61.1
38.9

62.3
37.7

0.36

50.0
50.0

43.2
56.8

0.78

61.1
38.9

49.1
50.9

0.66
52.4
47.6

43.2
56.8

0.78
61.1
38.9

49.1
50.9

0.37

0.48

73.8
26.2

67.6
32.4

83.3
16.7

75.5
24.5

42

37

18

53

*p<.05 **p<.01
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In Table 3, I present the results of a second cross-tabulation and chi-square tests
comparing respondents' agreement with certain items addressing perceived risk for the
Human Papillomavirus and respondents' age and relationship status. Again, similar to the
statements addressing sexual behavior responsibility, none of the items addressing
perceived risk for HPV were statistically related to either respondents' age or their
relationship status. Agreement with the first item, "Men are just as likely to contract the
Human Papillomavirus as women," is not statistically related to respondents' relationship
status. Of respondents who reported being single 62% agreed with this statement
compared with 38% of single respondents who disagreed with this statement. The
percentages for agreement were almost exactly the same for those respondents who
reported currently being in an exclusive relationship. Approximately 62% agreed with
this statement while approximately 38% disagreed. There is no difference in relationship
status between those who agreed with this statement and those who disagreed with it.
When compared to age, responses of agreement and disagreement were evenly split
between the two age categories identified earlier. There does not seem to be a pattern to
agreement or disagreement with these items and this could be because respondents do not
know a lot about the Human Papillomavirus and their perceptions of risk are not based on
actual knowledge.

Willingness to Vaccinate
Cross-tabulations were also conducted with these sets of items regarding sexual
behavior responsibility and perception of risk for the Human Papillomavirus and
participants' responses to the question regarding willingness to vaccinate to determine if
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there is a relationship between respondents' views on sexual behavior responsibility and
perceived risk for contracting the Human Papillomavirus and their willingness to protect
themselves if a male HPV vaccine ever becomes available.
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Table 4. Chi-square of Sexual Behavior Responsibility and Willingness to Vaccinate
Willingness to Vaccinate
No
Yes
3C2
%

%

Sexual Behavior Responsibility
It is the man who decides what type
of sex to have.
Agree
Disagree
It is a woman's responsibility to
avoid getting pregnant.
Agree
Disagree
I would be outraged if my sexual
partner asked me to use a condom.
Agree
Disagree

0.02
59.5
40.5

0.10
45.2
54.8

2.4
97.6

Total (n)

7.7
92.3
—
~

~

0.03
95.2
4.8

96.2
3.8
—

If a guy gets a woman pregnant, the
child is the responsibility of both.2
Agree
Disagree
A man and a woman should decide
together what type of contraceptive
to use.
Agree
Disagree

57.7
42.3
1.07

A couple should decide together if
they want to have children.2
Agree
Disagree
In my opinion, a woman can suggest
using a condom just like a man can.
Agree
Disagree

57.7
42.3

—

-

1.03

97.6
2.4

42

92.3
7.7

26

*p<.05 **p<.01
2

Percentages and chi-square score could not be calculated for these items as there was no comparison
between agree and disagree because none of the respondents disagreed with these statements.
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The first item in the section on sexual behavior responsibility asked participants to
provide the level with which they agreed with the statement: "It is the man who decides
what type of sex to have." A cross-tabulation and chi-square test was calculated between
this item and the participants' willingness to vaccinate. The results of this cross-tab
appear in Table 4. Of those participants who reported being willing to vaccinate against
HPV approximately 60% agreed with this statement while 40% disagreed. For the
participants who would not be willing to receive an HPV vaccine approximately 58%
agreed with this statement while 42% disagreed. A chi-square test suggests that this
relationship is not statistically significant.
The fifth item in this section of the survey asked for agreement with the following
statement: "In my opinion, a woman can suggest using a condom just like a man can."
Again, a cross-tab was generated to exam the relationship between this item and
willingness to vaccinate and the results can be found in Table 4. Of those who would be
willing to vaccinate against the Human Papillomavirus approximately 95% agreed with
this statement compared to 5% who disagreed. Of those who would not be willing to
vaccinate against HPV approximately 96% agreed with this statement compared to 4%
who disagreed. Again, a chi-square test of this relationship was not statistically
significant.
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Table 5. Chi-square of Perceived Risk for HPV and Willingness to Vaccinate
Wil ingness to Vaccinate
Yes
No
Z2
Perceived HPV Risk
Men are just as likely to contract
the Human Papillomavirus as
women.
Agree
Disagree
The medical complications of
HPV are just as severe for men
as they are for women.
Agree
Disagree
HPV is the leading cause of
penile and anal cancers in men.
Agree
Disagree
It is just as important for men to
protect themselves against HPV
as it is for women.
Agree
Disagree
Total (n)

2.17

71.4
28.6

53.9
46.1
0.38

50.0
50.0

57.7
42.3
0.01

54.8
45.2

53.9
46.1
1.66

85.7
14.3

73.1
26.9

42

26

*p<.05 **<.01
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Again, cross-tabulations and chi-square tests were conducted to examine the
relationship between perceptions of risk for HPV and willingness to vaccinate against the
virus. The results of these tests are presented in Table 5. None of the relationships
between any of these four items and willingness to vaccinate were statistically
significant. For example, the percentages for the cross-tabulation for agreement with item
3, "HPV is the leading cause of penile and anal cancers in men," and respondents'
willingness to vaccinate suggest that approximately 55% of those participants who would
be willing to vaccinate against HPV agreed with this statement, while 45% who would be
willing to vaccinate did not agree with this statement. The other three items in this section
were not statistically related to willingness to vaccinate.

Gardasil Campaign
The end of the survey addressed a series of points regarding the current Merck
Gardasil campaign. One question simply asked respondents how often in the last month
they had seen or heard a commercial for Gardasil. Responses were given on a four point
scale which ranges from 0-3 times, 4-6 times, 7-10 times, or 10 or more times. These
responses were compared to respondents' willingness to receive an HPV vaccine in order
to determine if there is a relationship between vaccine acceptance and exposure to the
current Gardasil campaign. The results of this cross-tabulation and chi-square test appear
in Table 6.
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Table 6. Chi-square of Willingness to Vaccinate and Exposure to Gardasil Commercials
Wil ingness to Vaccinate
No
Yes
#
5.08
Exposure to Gardasil Commercials
(in the past month)
0-3 times
4-6 times
7-10 times
10 times or more

90.5
9.5
0.0

80.8
7.7
11.5

Total (n)

42

26

*p<.05 **p<.01

The results in table 6 suggest that the number of times a participant has either
seen or heard a Gardasil commercial does not have an effect on whether or not
respondents would be willing to receive a Human Papillomavirus vaccine. There is not a
large difference between the percentages of those who would be willing to vaccinate and
whether they had seen or heard a Gardasil commercial 0-3 times in the past month or 4-6
times in the past month.
One open-ended response question asked respondent what they thought Gardasil
was. In order to examine these responses, the answers were categorized and frequencies
were tallied for each type. These results are presented in Table 7.
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Table 7. Open-ended responses to Gardasil Campaign Questions
Category of Response

n

%

Respondent cannot define the
word Gardasil

22

40.7

Respondent identified Gardasil
as a contraception for women

3

5.6

Respondent identified Gardasil
as a vaccine for women

4

7.4

Respondent identified Gardasil
as a cervical cancer prevention

8

14.8

Respondent identified Gardasil
as a HPV prevention
Total

17

31.5

54

100%

From Table 7 we can see that the majority of respondents, almost 41%, reported
not knowing what Gardasil is at all. The next most frequent category was those
respondents who knew that Gardasil is some type of HPV prevention. This does not mean
respondents were necessarily aware that Gardasil is a vaccine but that they knew what it
aimed to prevent. It should be noted that some respondents thought that Gardasil was a
type of contraception for women (5.6%) and some that that it was purely a cervical
cancer prevention tool (14.8%). The responses are interesting because they suggest an
ambiguity in understanding about the current HPV vaccine. This ambiguousness could
influence perceptions about the need for protection and the appropriateness of an HPV
vaccine for men.
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Summary
Overall, none of the results of the analysis between sexual behavior responsibility
or perception of risk for contracting the Human Papillomavirus and the medical
complications associated with it are statistically related to college men's willingness to
receive an HPV vaccine if one ever becomes available for them. None of the chi-square
tests that were conducted examining agreement with the items on sexual behavior
responsibility, respondents' age, relationship status, or willingness to vaccinate yielded
statistically significant results. The same is true for the chi-square tests examining
agreement with the items regarding perceived risk for HPV and respondents' age,
relationship status, or willingness to vaccinate.
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CHAPTER V

DISCUSSION/ CONCLUSION

Current medical research is aiming to establish a way to prevent high-risk strands
of the Human Papillomavirus in men. HPV is the most commonly spread sexually
transmitted infection in the United States and the cause of certain severe health problems,
specifically, high rates of cervical cancer in women. Presently there is a vaccine that has
been approved by the Federal Drug Administration for use in women that prevents for
high-risk strands of HPV. In order to understand whether or not men would be willing to
vaccinate themselves against the Human Papillomavirus it is important to investigate
possible predictors of decision making and behavior. This acceptance study has aimed to
look at two of these types of predictors, mainly, men's views on sexual behavior
responsibility and decision making and their perceived risk for contracting the Human
Papillomavirus and its medical complications.

Hypothesis I
The first hypothesis aimed to examine the relationship between men's perceptions
of risk for contracting the Human Papillomavirus and their willingness to receive an HPV
vaccine if one ever becomes available for men. In order to address this hypothesis, men
were asked to provide their level of agreement with a series of statements on this topic
and these responses were compared to their response to the willingness to vaccinate
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question. In order to investigate this relationship I conducted chi-square tests with
participants' agreement with each of these four items and their age, relationship status,
and whether or not they would be willing to vaccinate against HPV.
The first set of tests regarding perceived risk for HPV and respondents' age did
not yield any statistically significant results. It does not appear that older participants are
more informed about the Human Papillomavirus and their risk for contracting it
compared to younger participants or vice versa. This could be due to the fact that there is
not a very broad age range for participants. The age range was from 19 to 23 years old
and this could not be wide enough to detect any real difference in perception of risk for
HPV. Part of this could be the overall lack of knowledge among this age group. The
Human Papillomavirus has only recently been brought to public attention with the
creation and marketing of Gardasil so it could be that it is still widely unknown to young
adults, especially young men who have not been the target of HPV prevention education
so far.
The second set of tests examined whether or not there was a relationship between
perception of risk for HPV and respondents' relationship status. Again, it could be that
there is an overall lack of knowledge, or confusion, regarding the Human Papillomavirus
and men's risk for contracting the infection and this overall confusion exists regardless of
whether or not men are in an exclusive relationship. It is surprising that there is not a
difference between those respondents who report being single compared to those who
report being in an exclusive relationship in regards to whether or not they feel it is
necessary for men to protect themselves against HPV. It could be that responses to these
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items were based on how responses feel about all men instead of making a judgment for
themselves.
The final set of statistical tests for this hypothesis examined the relationship
between perception of risk and respondents' willingness to vaccinate themselves against
HPV. It was hypothesized that the greater the level of perceived risk for HPV, the more
likely respondents' would be to be willing to vaccinate against the virus. Again, this
relationship was not statistically significant. Previous research found that one's level of
knowledge about the Human Papillomavirus and related issues like cervical cancer did
not affect the decision to vaccinate either one's self or one's child (Dempsey et al., 2006,
Lenselink et al., 2007 and 2008). This could also be the case with this particular study.
Perhaps individuals' willingness to vaccinate is based more on the suggestion of the
medical field instead of what they know about particular diseases and preventions.

Hypothesis II
The second hypothesis investigated the relationship between respondents' level of
sexual behavior responsibility and their willingness to vaccinate themselves against the
Human Papillomavirus vaccine. In order to test this hypothesis I ran a number of
statistical analyses comparing respondents' agreement with the seven sexual behavior
responsibility items with their age, relationship status, and finally, with their reported
willingness to vaccinate against the Human Papillomavirus.
Initially, I investigated whether or not there was a relationship between
participants' agreement with the items regarding sexual behavior responsibility and age.
While none of the statistical analyses yielded significant results there were some patterns
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in responses to some of the items. These patterns seem to suggest that younger
respondents are more apt to think that men should make sexual behavior decisions
without taking their partner's opinion into consideration. This could suggest a difference
in level of maturity among respondents but again this relationship was not statistically
significant so it is not possible to say that respondents' agreement with this statement is
contingent on their age.
I also looked at the relationship between agreement with the sexual behavior
responsibility items and relationship status. Again while there were not any statistical
significant relationships it seems that those who are committed to their sexual partner
would not expect their partner to ask them to use protection, while those who are single
or who are casually dating think it acceptable for their sexual partner to suggest using
protection. It could be that participants in committed relationships do not feel that
contraception and sexually transmitted infection protection is as necessary because they
are only involved with one person. Another possible explanation could be that men who
are involved in a committed relationship have already established what type of
protection, if any, they would use to prevent unwanted pregnancy and to raise these
questions with their partner again may seem unnecessary or even insulting.
The final set of analyses which looked at respondents' agreement with the sexual
behavior items and their willingness to vaccinate against HPV also did not result in any
statistically significant relationships. It was hypothesized that men who felt that
contraceptive use was a woman's responsibility would be less willing to vaccinate
because a vaccine for a sexually transmitted infection would be viewed as another "safe
sex" practice. One possible explanation is that the items used to address sexual behavior
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responsibility do not deal with who men feel should be responsible for practicing safe sex
but instead address men's attitudes towards sexual behavior.
This lack of relationship is interesting when compared to previous research on
similar topics, such as the work done by Oudshoorn (2003). Oudshoorn's book, The Male
Pill, addressed the effect of male responsibility for family planning during the initial
development of a male contraceptive pill. Oudshoorn (2003) suggested that in order for a
male contraceptive pill to gain acceptance men would have to be included more in the
larger area of family planning and be encouraged to be responsible for contraceptive use.
The author sees this as one of the most important obstacles in overcoming the barriers to
introduction and uptake of a male pill (Oudshoorn, 2003). It seems logical that this line of
reasoning could be extended to prevention of sexually transmitted infections, especially
those that, similar to unwanted pregnancies, affect women in more obvious ways than
men.
This study did not find a relationship between responsibility and acceptance that
could be related to Oudshoorn's work. It could be that men do not view vaccinating
against sexually transmitted infections in the same way that they view contraceptive use
or other sexual behavior issues, like dealing with unplanned pregnancies. Perhaps there is
a difference between vaccinating against the Human Papillomavirus and male
contraceptive pills because the HPV vaccine for women has not been available long
enough to have made a stereotypical impression on our views about protection and
prevention. If the Gardasil vaccine for women remains the only HPV prevention tool then
perhaps in the future there would be a difference in opinion about men's willingness to
vaccinate themselves. It could be that, similar to a possible lack of knowledge

46

surrounding HPV, men also have not yet been socialized to believe that the HPV vaccine
is purely a women's health issue.
Another possible explanation could be that developments in areas like male
contraception have made it easier for other new technologies, like sexually transmitted
infection vaccines, to gain acceptance because there has already been some discussion
surrounding male involvement in sexual behavior responsibility. It may be that the
history of the male pill which Oudshoorn (2003) outlined in her book has affected the
way college men view the Human Papillomavirus vaccine. It is difficult to tell if this is an
issue surrounding time or if men's perceptions about vaccination are different then their
views on sexual behavior responsibility and contraceptive use.

Hypothesis III
The third and final hypothesis for this study aimed to understand if there was any
relationship between exposure to the current Gardasil campaign and willingness to
vaccinate against the Human Papillomavirus vaccine. Statistical analyses of the items in
the survey addressing exposure to the Gardasil campaign and knowledge about Gardasil
with vaccine acceptance suggested that there is no statistically significant relationship
between exposure to the campaign and acceptance. It could be that perhaps individuals
may not pay much attention to the commercials they are viewing, especially if the
characters featured are not of the same demographic characteristics. The Gardasil
campaign has worked very hard to target mothers and girls and perhaps they are
accomplishing their goal by attracting women and subsequently disregarding men. It
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seems that despite the level of exposure to Gardasil or knowledge about the vaccine, the
majority of college men are willing to vaccinate.

The lack of statistical significance in these analyses could be due to the fact that
the majority of college men, approximately 60% would be willing to receive an HPV
vaccine and only 7% reported that they would be unwilling. It seems that regardless of
how this sample feels about sexual behavior responsibility or what they believe about the
Human Papillomavirus, they are willing to receive a vaccine. Could this be the result of a
generation that has been raised to believe that vaccines, regardless of their risks or
consequences, are a good thing? It may be due to the fact that because this generation has
been receiving vaccines since birth that they do not question whether or not they should
receive a particular vaccine. This willingness to vaccinate may be the result of a larger
generational attitude towards vaccination instead of a gender specific attitude regarding
sexual behavior responsibility and sexually transmitted infection prevention.

Limitations
There are several limitations to this study, most of which center around the
methodology. These limitations are issues that should be addressed in future research in
order to obtain a more accurate understanding of male HPV vaccine acceptance. The
largest limitation in this study is the sample size and efforts should be made in the future
to try and establish a larger, more representative sample. There was a difficulty in
establishing both access to a male population for sampling and an actual sample of male
participants. I think there is a specific difficulty in addressing this particular type of
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population, male college students around twenty years old. As discussed earlier in the
methods chapter, there may also be an effect of response bias because there may be
something fundamentally different between those college men who chose to participate in
this study compared to those who chose not to participate. While efforts were made to
obtain participants with a raffle drawing incentive, it may have been easier to get
participants if a larger incentive could have been provided. This was not possible for this
study as there was not any grant or outside funding support. It may be necessary to obtain
such support for a future study.
As a result of this the small sample size, responses were collapsed for some items,
most importantly the item which addressed participants' willingness to vaccinate. This is
problematic because respondents who actually reported feeling neutral about the decision
to vaccinate may actually not have thought about their willingness to vaccinate as much
as those who made a decision either way. They also may not have as much knowledge
about the Human Papillomavirus or the vaccine compared to those who reported being
willing or unwilling to vaccinate or they may not be willing to vaccinate at the time this
study was conducted but would be willing to vaccinate at some later time. Therefore, this
may affect the results because the difference between the two groups may not be as
apparent if the neutral responses were influencing the group which was considered
"unwilling" to vaccinate.
Another limitation to this study would be the extensiveness of the survey. I think
it would be interesting for a future study to try and expand on the current survey and
perhaps use scales to gain a level of sexual behavior responsibility or perceived risk. It
may be helpful to compare participants based on levels of these categories instead of
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having to look at each individual item in these categories as this study did. It may also be
more beneficial to include more items under each of the sections of this survey to gain a
better understanding of perceived risk and responsibility. Like other studies that have
looked at different populations' acceptability (e.g., Dempsey et al., 2006, Lenselink et al.,
2008) it may also be helpful to include a measure of participants' level of knowledge
about HPV and the vaccine and use an assessment that could rate how much they actually
know about the infection and vaccine. Further ideas for future research in this area are
presented in the next section.

Future Research
Vaccines for sexually transmitted infections are part of a rapidly expanding
medical field and it is important to have research within the social sciences to accompany
the medical field in order to understand the effects of one on the other. The Human
Papillomavirus and its accompanying vaccine are undergoing great advancements right
now and social science research should aim to keep up with the medical field.
Specifically, while the Human Papillomavirus has previously been considered primarily a
women's health issue, the medical field has begun to turn its attention towards men as
research aims to create HPV tests for men and vaccines for male prevention.
A future study may gain more insightful information by using in-depth interviews
and focus groups to understand what men know about the Human Papillomavirus and
how they feel they should be included in preventing against the infection and other
sexually transmitted infections. The current study has really only provided an
introduction to understanding the relationship between men's perceptions about risk and
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responsibility and willingness to vaccinate. It is important that future research use larger
statistical methods as well as mixed-methods approaches to gain further insight into male
attitudes and beliefs that could affect behavior. Acceptability studies are important
components to new medical technologies and future work in this area should aim to
expand and deepen the understandings that this study has just begun to touch on.
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APPENDIX A

RECRUITMENT LETTER
Dear Professor

,

My name is Angela Mitiguy and I am a second year Master's student in the
Sociology Department. I am currently working on my Master's thesis and was hoping I
could ask your assistance with my data collection. The purpose of my project is to
investigate male college student's acceptance of a possible Human Papillomavirus
vaccine for men. I am hoping to survey men here at UNH in regards to their beliefs about
the HPV vaccine and their willingness to receive a vaccine. I would like to sample men
who are enrolled in courses that could fulfill general education requirements for the
college in order to get the broadest sample possible. In order to do this I am sampling
students from courses that count towards UNH's general education requirements. Your
class,
, was chosen by random selection to participate in this
study.
I hope to collect my data as soon as possible. In order to do this I am hoping that
you will be willing to provide your male students with an internet link to an online survey
provided either via blackboard or during class. They could go to the website whenever
they like and complete the survey in their own time. There would be a raffle incentive for
those who choose to participate.
My project has been approved by the IRB at UNH. If you have any further
questions please feel free to contact me or my faculty advisor, Dr. Sharyn Potter in the
Sociology Department at Sharyn.Potter@unh.edu. If you would be willing to help me in
this endeavor, I ask that you please e-mail me back. If you choose to participate then I
will be in further contact with you soon. Thank you so much for taking the time to read
and consider this. I look forward to hearing from you.
Sincerely,
Angela Mitiguy
Master's Student
Sociology Department
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APPENDIX B

CONSENT FORM
Title of Study: Male Attitudes Regarding Current Public Health Issues
Principal Investigator: Angela Mitiguy, University of New Hampshire
Purpose of Study: This study is designed to investigate male attitudes and beliefs about
a public health issue.
Procedure: You will be asked to complete a brief survey aimed at helping researchers
understand men's attitudes towards a current public health issue. The survey should take
you about 5 minutes to complete.
Possible risks and benefits: A possible risk may be discomfort or anxiety that results
from the sensitive nature of some of the questions. These are no direct benefits to the
participant from participating in this study.
Confidentiality of records: All records generated by this study will be confidential, to
the extent possible when communicating via the internet. Paper records will only be
available to researchers involved in this study. You will not be individually identified in
any paper that may result from this project.
Voluntary nature of participation: Participation in this study is completely voluntary
and you may withdraw from participation at any point. You are free to refuse to answer
any question in the survey.
Request for more information: Please feel free to ask any questions you may have
about this study. I will be happy to inform you of the results of the study when they are
available. If you wish to speak with someone involved in this study regarding any
problems or concerns you may have, contact the principal investigator, Angela Mitiguy at
amx72@unh.edu. This study has been approved by the Institutional Review Board at the
University of New Hampshire. If you have any questions about your rights as a research
subject you can contact Julie Simpson in the UNH Office of Sponsored Research, 603862-2003 or Julie.simpson@unh.edu to discuss them.
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I have read and I understand this consent form. Therefore, I agree to give my consent to
participate as a subject in this research project.

* 1. Please check the appropriate box:
J I understand the above statements and wish to continue with the survey.
_J I decline to participate in this survey.
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APPENDIX C

SURVEY
Demographics:
1. How old are you in years?
1.18 years old
2. 19 years old
3. 20 years old
4. 21 years old
5. 22 years old
6. 23+ years old
2. What is your college major?
3. Which best describes your current marital status?
1. Single
2. Casually dating
3. In a serious relationship
4. Cohabiting with partner
5. Married
4. Are you an in-state or out-of-state student?
1. In-state
2. Out-of-state

Sexual Responsibility:
(1) Agree, (2) Partially Agree, (3) Do Not Agree
1. It is the man who decides what type of sex to have.
2. It is a woman's responsibility to avoid getting pregnant.
3.1 would be outraged if my sexual partner asked me to use a condom.
4. A couple should decide together if they want to have children.
5. In my opinion, a woman can suggest using a condom just like a man can.

58

6. If a guy gets a woman pregnant, the child is the responsibility of both.
7. A man and a woman should decide together what type of contraceptive to use.

Risk:
(1) Agree, (2) Partially Agree, (3) Do Not Agree
1. Men are just as likely to contract the Human Papillomavirus as women.
2. The medical complications of HPV are just as severe for men as they are for women.
3. HPV is the leading cause of penile and anal cancers in men.
4. It is just as important for men to protect themselves against HPV as it is for women.
Exposure to HPV Vaccine Commercials:
1. Can you tell me what Gardasil is?

2. In the past month how many times have you seen or heard commercials for Gardasil?
1. 0-3 times
2. 4-6 times
3. 7-10 times
4. 10 or more times
3. If you have seen any Gardasil commercials, can you list anything that you remember
from the commercial?

Willingness to receive an HPV vaccine:
If one ever became available for men, how willing would you be to receive a Human
Papillomavirus vaccine? Please disregard such issues as insurance coverage or cost.
1. Very willing
2. Somewhat willing
3. Neither willing nor unwilling
4. Somewhat unwilling
5. Very unwilling
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APPENDIX D

RESOURCES FOR PARTICIPANTS
We know that sexually transmitted infections and sexual behavior is a sensitive topic.
After participating in this study, you might want to talk to someone for support and to
gain more information. This is a list of organizations that are here to help you for any
reason as well as a list of websites that provide information about the Human
Papillomavirus and the current ways to prevent it. Again, you may also choose to contact
the researcher as well.
On Campus:
UNH Counseling Center

862-2090

UNH Health Services

862-1530

Off Campus:
Planned Parenthood (Portsmouth Health Center)

431-6803

Wentworth Douglass Hospital

742-5252

Human Papillomavirus Websites:
Centers for Disease Control
Gardasil Vaccine

http://www.cdc.gov/std/hpv/default.htm
www.gardasil.com

Researcher:
Angela Mitiguy

amx72@unh.edu
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APPENDIX E

INSTITUTIONAL REVIEW BOARD APPROVAL FOR THE USE OF
HUMAN SUBJECTS

University of New Hampshire
Research Conduct and Compliance Services, Office of Sponsored Research
Service Building, 51 College Road, Durham, NH 03824-3585
Fax: 603-862-3564

20-Jan-2009
Mitiguy, Angela
Sociology, Horton SSC
16 Moon Brook Drive
Rutland, VT 05701
IRB # : 4460
Study: The Effects of Perceived Risk and Responsibility on the Acceptance of a Human
Papillomavirus Vaccine by College Men
Approval Date: 13-Jan-2009
The Institutional Review Board for the Protection of Human Subjects in Research (IRB) has
reviewed and approved the protocol for your study as Exempt as described in Title 45, Code of
Federal Regulations (CFR), Part 46, Subsection 101(b). Approval is granted to conduct your
study as described in your protocol.
Researchers who conduct studies involving human subjects have responsibilities as outlined in
the attached document, Responsibilities of Directors of Research Studies Involving Human
Subjects. (This document is also available at http://www.unh.edu/osr/compliance/irb.html.)
Please read this document carefully before commencing your work involving human subjects.
Upon completion of your study, please complete the enclosed Exempt Study Final Report form
and return it to this office along with a report of your findings,*'*
If you have questions or concerns about your study or this approval, please feel free to contact
me at 603-862-2003 or Julie.simpson@unh.edu. Please refer to the IRB # above in all
correspondence related to this study. The IRB wishes you success with your research.

For the IRB,

cc: File
Potter, Sharyn
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